scholarly article | Q13442814 |
P50 | author | Tian-Fu Wen | Q111586918 |
P2093 | author name string | Bo Li | |
Jin Li | |||
Zhe-Yu Chen | |||
Jian Yang | |||
Yong Zeng | |||
Ji-Chun Zhao | |||
Jia-Yin Yang | |||
Lu-Nan Yan | |||
Ming-Qing Xu | |||
Wen-Tao Wang | |||
Yu-Kui Ma | |||
P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis | Q34515064 | ||
Prognostic prediction and treatment strategy in hepatocellular carcinoma. | Q34547469 | ||
Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified? | Q36098393 | ||
Indications for liver transplantation in hepatobiliary malignancy | Q40658075 | ||
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? | Q40780775 | ||
Hepatic resection versus transplantation for hepatocellular carcinoma | Q43946793 | ||
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients | Q44498208 | ||
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience | Q44654109 | ||
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan | Q45258006 | ||
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 | ||
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome | Q47240294 | ||
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. | Q50951290 | ||
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma | Q61937491 | ||
Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma | Q72511270 | ||
Milan multicenter experience in liver transplantation for hepatocellular carcinoma | Q72901682 | ||
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma | Q73433778 | ||
Liver organ allocation for hepatocellular carcinoma: are we sure? | Q73576939 | ||
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters | Q77847343 | ||
Liver transplantation for hepatocellular carcinoma | Q78347522 | ||
Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria | Q81498523 | ||
P433 | issue | 33 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 4170-4176 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients | |
P478 | volume | 15 |
Q38059620 | A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. |
Q37619486 | Adult to adult right lobe living donor liver transplantation: does biological relationship matter? |
Q36111140 | Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma? |
Q51773097 | Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases. |
Q47566919 | Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. |
Q82978560 | Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma |
Q57494813 | Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) |
Q40603978 | Impact of Histological Factors of Hepatocellular Carcinoma on the Outcome of Liver Transplantation |
Q37795703 | Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart? |
Q38046482 | Liver transplantation and expanded Milan criteria: does it really work? |
Q26750463 | Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review |
Q87010059 | Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience |
Q34067940 | Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation |
Q89953527 | Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma |
Q37708048 | Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison |
Q64943233 | Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. |
Q37378982 | Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation |
Q38615125 | Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma |
Q43467782 | Predictors of patient survival following living donor liver transplantation. |
Q38243059 | Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria |
Q60912071 | Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy? |
Q33913779 | Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. |
Q37876384 | Which matters most: number of tumors, size of the largest tumor, or total tumor volume? |
Search more.